The first single view of the risk and reward of the R&D landscape
Track and analyse clinical trials in the commercial context with ClinicalTrials.gov, EudraCT and a Japan clinical trials data source aggregated, standardised and integrated.
Identify and track future critical events and market catalysts for product lifecycles. Track key events, including Phase II and III trial initiation, completion and results, financial results, product filings and approvals, and expected generic competition.
Access NPV discounted cash flow models for over 4,500 products. Interactive, fully transparent models let you edit key assumptions – annual and peak sales, patent expiry date, cost of capital and tax rate – to create a custom model.
“ We know Evaluate has done the work and looked at the data, and we trust the answers they give us. Our management is happy when they see Evaluate's name. ”
“ Evaluate's consensus forecasts commentary highlights the main drivers of a forecast - knowledge that's critical when I am working with brand teams or the C-suite executives. ”